These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8939634

  • 1. The new generation of recombinant viral subunit vaccines.
    Ellis RW.
    Curr Opin Biotechnol; 1996 Dec; 7(6):646-52. PubMed ID: 8939634
    [Abstract] [Full Text] [Related]

  • 2. Gene cloning to study viral antigens: prospects for novel influenza and rotavirus vaccines.
    Both GW, Jennings PA.
    Prog Vet Microbiol Immunol; 1987 Dec; 3():179-213. PubMed ID: 2856220
    [No Abstract] [Full Text] [Related]

  • 3. Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins.
    Dormitzer PR, Ho DY, Mackow ER, Mocarski ES, Greenberg HB.
    Virology; 1992 Mar; 187(1):18-32. PubMed ID: 1371025
    [Abstract] [Full Text] [Related]

  • 4. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ, Granzow H, Schuldt K, Whitehead SS, Murphy BR, Collins PL.
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology.
    de Waal L, Wyatt LS, Yüksel S, van Amerongen G, Moss B, Niesters HG, Osterhaus AD, de Swart RL.
    Vaccine; 2004 Feb 25; 22(8):923-6. PubMed ID: 15161069
    [Abstract] [Full Text] [Related]

  • 7. The iscom antigen-presenting system.
    Morein B.
    Nature; 1988 Mar 17; 332(6161):287-8. PubMed ID: 3347272
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In this issue: shifting the focus to modern vaccinology.
    Bot A.
    Int Rev Immunol; 2009 Mar 17; 28(1):1-3. PubMed ID: 19241249
    [No Abstract] [Full Text] [Related]

  • 11. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
    Crowe JE, Collins PL, London WT, Chanock RM, Murphy BR.
    Vaccine; 1993 Nov 17; 11(14):1395-404. PubMed ID: 8310760
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Viral vaccines under development: a third generation.
    Osborn JE.
    Adv Exp Med Biol; 1979 Nov 17; 118():61-82. PubMed ID: 227237
    [Abstract] [Full Text] [Related]

  • 17. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM, Huang CY.
    Intervirology; 2001 Nov 17; 44(2-3):176-97. PubMed ID: 11509879
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.
    Murphy BR, Collins PL.
    J Clin Invest; 2002 Jul 17; 110(1):21-7. PubMed ID: 12093883
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.